Skip to main navigation Skip to search Skip to main content

The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)

  • Giulio G Stefanini
  • , Patrick W Serruys
  • , Sigmund Silber
  • , Ahmed A Khattab
  • , Robert J van Geuns
  • , Gert Richardt
  • , Pawel E Buszman
  • , Henning Kelbæk
  • , Adrianus J van Boven
  • , Sjoerd H Hofma
  • , Axel Linke
  • , Volker Klauss
  • , William Wijns
  • , Carlos Macaya
  • , Philippe Garot
  • , Carlo Di Mario
  • , Ganesh Manoharan
  • , Ran Kornowski
  • , Thomas Ischinger
  • , Antonio L Bartorelli
  • Pierre Gobbens, Stephan Windecker
    106 Citations (Scopus)

    Abstract

    The aim of this study was to investigate the impact of patient and lesion complexity on outcomes with newer-generation zotarolimus-eluting stents (ZES) and everolimus-eluting stents (EES).
    Original languageEnglish
    JournalAmerican College of Cardiology. Journal
    Volume57
    Issue number22
    Pages (from-to)2221-32
    Number of pages12
    ISSN0735-1097
    DOIs
    Publication statusPublished - 2011

    Keywords

    • Acute Coronary Syndrome
    • Aged
    • Angioplasty, Balloon, Coronary
    • Coronary Angiography
    • Coronary Artery Disease
    • Coronary Stenosis
    • Drug-Eluting Stents
    • Female
    • Humans
    • Immunosuppressive Agents
    • Male
    • Middle Aged
    • Myocardial Infarction
    • Myocardial Ischemia
    • Sirolimus
    • Treatment Outcome

    Fingerprint

    Dive into the research topics of 'The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)'. Together they form a unique fingerprint.

    Cite this